PERRIGO Co plc (PRGO) stock
PRGONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 9/3010% below fair value
$15.76−0.42 (-2.60%)
Close on Nov 17, 2026Market cap $2.19BP/E –Yield 7.36%
Perrigo operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Perrigo's operating cash flow for the twelve months ending Jun 27, 2026 was $196.10M, down 46.5% year over year. For fiscal 2025 it was $238.50M, down 34.3% from the year before. Over ten years it grew -9.3% a year on average. The highest annual figure on record is $855.20M in fiscal 2015.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $238.50M | -34.3% |
| FY2024 | Dec 31, 2024 | $362.90M | -10.5% |
| FY2023 | Dec 31, 2023 | $405.50M | +32.0% |
| FY2022 | Dec 31, 2022 | $307.30M | +96.6% |
| FY2021 | Dec 31, 2021 | $156.30M | -75.4% |
| FY2020 | Dec 31, 2020 | $636.20M | +64.1% |
| FY2019 | Dec 31, 2019 | $387.80M | -34.6% |
| FY2018 | Dec 31, 2018 | $593.00M | -15.2% |
| FY2017 | Dec 31, 2017 | $698.90M | -18.3% |
| FY2015 | Jun 27, 2015 | $855.20M | +35.1% |
| FY2014 | Jun 28, 2014 | $633.00M | +14.3% |
| FY2013 | Jun 29, 2013 | $553.80M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 27, 2026 | $82.60M | +8.8% |
| Q1 FY2026CQ1 2026 | Mar 28, 2026 | -$113.60M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $175.40M | -43.9% |
| Q3 FY2025CQ3 2025 | Sep 27, 2025 | $51.70M | +22.5% |
| Q2 FY2025CQ2 2025 | Jun 28, 2025 | $75.90M | +698.9% |
| Q1 FY2025CQ1 2025 | Mar 29, 2025 | -$64.50M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $312.60M | +49.8% |
| Q3 FY2024CQ3 2024 | Sep 28, 2024 | $42.20M | -66.1% |
| Q2 FY2024CQ2 2024 | Jun 29, 2024 | $9.50M | -82.0% |
| Q1 FY2024CQ1 2024 | Mar 30, 2024 | -$1.40M | -107.2% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $208.70M | +12.3% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $124.50M | +110.3% |
| Q2 FY2023CQ2 2023 | Jul 1, 2023 | $52.90M | – |
| Q1 FY2023CQ1 2023 | Apr 1, 2023 | $19.40M | -75.5% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $185.90M | – |
| Q3 FY2022CQ3 2022 | Oct 1, 2022 | $59.20M | -82.8% |
| Q2 FY2022CQ2 2022 | Jul 2, 2022 | -$16.90M | – |
| Q1 FY2022CQ1 2022 | Apr 2, 2022 | $79.10M | +39450.0% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -$105.40M | -195.5% |
| Q3 FY2021CQ3 2021 | Oct 2, 2021 | $343.80M | +444.8% |
| Q2 FY2021CQ2 2021 | Jul 3, 2021 | -$82.30M | -128.3% |
| Q1 FY2021CQ1 2021 | Apr 3, 2021 | $200.00K | -99.9% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $110.40M | +23.4% |
| Q3 FY2020CQ3 2020 | Sep 26, 2020 | $63.10M | -54.9% |
| Q2 FY2020CQ2 2020 | Jun 27, 2020 | $290.90M | +356.0% |
| Q1 FY2020CQ1 2020 | Mar 28, 2020 | $171.80M | +81.8% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $89.50M | -53.9% |
| Q3 FY2019CQ3 2019 | Sep 28, 2019 | $140.00M | -2.8% |
| Q2 FY2019CQ2 2019 | Jun 29, 2019 | $63.80M | -22.5% |
| Q1 FY2019CQ1 2019 | Mar 30, 2019 | $94.50M | -45.2% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $194.30M | -10.4% |
| Q3 FY2018CQ3 2018 | Sep 29, 2018 | $144.00M | -26.8% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $82.30M | -9.4% |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | $172.40M | -11.4% |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | $216.90M | +81.4% |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | $196.70M | +9.2% |
| Q2 FY2017CQ2 2017 | Jul 1, 2017 | $90.80M | – |
| Q1 FY2017CQ1 2017 | Apr 1, 2017 | $194.50M | – |
| Q4 FY2015CQ2 2015 | Jun 27, 2015 | $119.60M | – |
| Q3 FY2015CQ1 2015 | Mar 28, 2015 | $180.20M | – |
See a number that looks wrong?